logo

For the Inventor, By the Inventor

Deerfield, IL, United States of America

Kathy A Sarris

This inventor holds 16 USPTO granted patents. Top assignees: Abbvie Inc., Abbott Laboratories Corporation. Active years: 2008-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kathy A Sarris. Retrieved from https://idiyas.com/inventor/kathy-a-sarris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 75.0

Average Co-Inventor Count = 15.9

ph-index = 7

Forward Citations = 158(Granted Patents)


Location History:

  • Buffalo Grove, IL (US) (2008 - 2010)
  • Deerfield, IL (US) (2010 - 2014)
  • Mundelein, IL (US) (2014 - 2019)

Company Filing History:

goldMedal12 out of 826 
 
Abbvie Inc.
 patents
silverMedal4 out of 4,188 
 
Abbott Laboratories Corporation
 patents

Years Active: 2008-2019

Loading Chart...
16 patents (USPTO):Explore Patents
1. 10233179 - Thiazoles and uses thereof (2019-03-19),
2. 10039754 - Anti-viral compounds (2018-08-07),
3. 10028937 - Anti-viral compounds (2018-07-24),
4. 9777020 - Furo-3-carboxamide derivatives and methods of use (2017-10-03),
5. 9586978 - Anti-viral compounds (2017-03-07),
6. 9163007 - 5-substituted indazoles as kinase inhibitors (2015-10-20),
7. 9006387 - Anti-viral compounds (2015-04-14),
8. 8937150 - Anti-viral compounds (2015-01-20),
9. 8921514 - Anti-viral compounds (2014-12-30),
10. 8691938 - Anti-viral compounds (2014-04-08),
11. 8648069 - 5-substituted indazoles as kinase inhibitors (2014-02-11),
12. 8470813 - Thiazoline and oxazoline derivatives and their methods of use (2013-06-25),
13. 8183250 - Potent PARP inhibitors (2012-05-22),
14. 7683084 - Thiazoline and oxazoline derivatives and their methods of use (2010-03-23),
15. 7671076 - Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) (2010-03-02),

Title: Kathy A Sarris: Pioneering Innovator in Antiviral Technology

Introduction:

Kathy A Sarris, a prolific inventor based in Deerfield, IL, has made significant contributions to the field of antiviral technology. Her passion for innovation and unwavering commitment to excellence continue to inspire a new generation of inventors.

Latest Patents:

With a portfolio of 16 patents, Kathy A Sarris is a trailblazer in the development of antiviral compounds. Her latest patents include "Thiazoles and uses thereof," which inhibit RSV infection, and "Anti-viral compounds," effective in combating Hepatitis C virus.

Career Highlights:

Having worked at prominent companies such as AbbVie Inc. and Abbott Laboratories Corporation, Kathy A Sarris has honed her skills and expertise in the pharmaceutical industry. Her groundbreaking research has led to the development of novel antiviral treatments.

Collaborations:

During her career, Kathy A Sarris has collaborated with esteemed professionals such as Kevin R Woller and David A DeGoey. Together, they have spearheaded innovative research projects that have revolutionized the field of antiviral therapeutics.

Conclusion:

In conclusion, Kathy A Sarris's remarkable achievements serve as a testament to the power of creativity and perseverance in driving positive change within the realm of technology. Her continued dedication to advancing antiviral research paves the way for a healthier and more sustainable future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…